O crescimento de investimentos em biotecnologia na agricultura tem sido um elemento primordial para a segurança alimentar global. Isso tem levado a uma reorganização da indústria mundial de sementes na busca por técnicas mais adequadas de cultivo, mecanização, uso de fertilizantes, defensivos agrícolas e a utilização de sementes. O Brasil por ser um dos ambientes mais sólidos nesse contexto tem contribuído com o crescimento e a diversificação da produção de sementes levando as lavouras brasileiras a atingirem um novo patamar de produtividade. Diferentes metodologias estatísticas têm sido utilizadas para analisar o comportamento da germinação de uma população de sementes. Entretanto, usar abordagens estatísticas que analisam os dados de germinação da melhor maneira possível permitirá uma maior confiabilidade dos resultados, bem como, ganho de informações pertinentes. Como em testes de germinação de sementes estuda-se o tempo até a ocorrência do evento, que envolve medidas repetidas feitas no mesmo lote e não se conhece o tempo exato da germinação da semente, propõe-se o uso de modelos de dose-resposta com censura intervalar, que permitem a interpretação biológica dos parâmetros usados para medir o processo germinativo e refletem o desenho experimental dos dados. Neste trabalho foram utilizadas duas metodologias estatísticas usuais na análise de dados de germinação de sementes e seus resultados foram comparados com os da abordagem de modelos dose-resposta com censura intervalar. Foram utilizados os modelos de dose-resposta Weibull 2 e log-logístico para explicar o processo germinativo de sementes de Brachiaria e Citrumelo Swingle respectivamente, com diferentes tempos de observação. Os experimentos foram realizados em delineamento inteiramente aleatorizado e os procedimentos dos testes de germinação de acordo com as Regras para Análise de Sementes (RAS). As conclusões obtidas a partir da análise dos dados por meio da metodologia proposta, em geral, divergiram das conclusões obtidas por abordagens tradicionais (modelos de regressão não-linear considerando a distribuição normal e índices de germinação com o uso da análise de variância) utilizadas para analisar dados de germinação. Os modelos de dose-resposta com censura intervalar apresentaram ajustes satisfatórios e sendo portanto uma análise mais adequada que as abordagens usuais. / The growth of investment in biotechnology in agriculture has been a vital element for global food security. This has led to a reorganization of the world seed industry in the seeking of the most appropriate techniques of cultivation, mechanization, use of fertilizers, pesticides and seeds. The Brazil for being one of the most solid in the world context of the seed industry has contributed to the growth and diversification of seed production, leading Brazilian crops to a new level of productivity. Different statistical methodologies have been used to analyze the germination behavior. However, using statistical approaches that analyze germination data as efficiently as possible will allow a greater reliability of the results, as well as relevant information gain. As in seed germination test studies the time until the occurrence of the event, involves repeated measurements on the same experimental unit and do not know the exact time of germination, we propose the use of dose-response models with interval censured that allow biological interpretation of parameters used to measure the germination process and reflect the experimental design of the germination data. In this work we used two methodologies of usual statistical analysis and their results were compared with those of the approach that uses the dose-response models with interval censured. We used the dose response models Weibull 2 and log-logistic to explain the process of seed germination of Brachiaria and Citrumelo Swingle with different observation times. The experiments were carried out in completely randomized design and testing procedures according to the rules for seed analysis (RAS). The conclusions obtained from the analysis of the data by the proposed methodology in general diverged from the conclusions obtained by traditional approaches (regression models nonlinear considering normal distribution and germination indices using analysis of variance) used to analyze data germination. The dose-response models with interval-censored showed satisfactory adjustments and therefore a more accurate analysis than the usual approaches.

O prognóstico de pacientes portadores de sarcomas de partes moles (SPM) avançados é reservado. Aumentar o benefício de quimioterapia é necessário, sendo, uma das estratégias, quimioterapia em dose densa, a qual demonstrou benefício em câncer de mama. Por outro lado, a busca de um marcador prognóstico é importante para uma melhor seleção de pacientes que se beneficiariam de protocolo de tratamento mais intensivo. A ezrina é uma proteína que liga o citoesqueleto celular a proteínas de membrana, está associada a invasão celular e metástase e sua hiperexpressão tem sido associada a um pior prognóstico em sarcomas de partes moles. O objetivo deste estudo foi avaliar o papel de quimioterapia com dose densa em pacientes portadores de SPM de alto grau, avançados. O desfecho primário foi taxa de resposta e os secundários foram sobrevida global (SG), sobrevida livre de progressão (SLP), perfil de toxicidade, qualidade de vida e controle de dor. Avaliou-se também a expressão de ezrina por imunohistoquímica como marcador de prognóstico, com o intuito de estratificação da população que poderia se beneficiar mais desta abordagem intensificada. Neste estudo de fase II prospectivo, vinte e um pacientes foram incluídos. A idade mediana foi 37 anos (23-60) e extremidades inferiores foram o sítio primário mais comum. Sarcoma sinovial, leiomiossarcoma e sarcoma sem outras especificações foram as histologias mais frequentes. O protocolo consistiu de seis ciclos seqüenciais de doxorubicina 30mg/m2 D1-3 e ifosfamida 2,5g/m2 D1-5 a cada 14 e 21 dias, respectivamente, seguidos por sete dias de suporte hematopoiético. As intensidades de dose medianas de doxorrubicina e ifosfamida foram, respectivamente, 42mg/m2/semana e 3,63g/m2/semana (93% e 87% do planejado, respectivamente) e 15 pacientes (71%) receberam todo o tratamento. Toxicidades graus 3 e 4 foram observadas em 19 pacientes e em 77/105 ciclos, neutropenia febril em 6 ciclos (5 pacientes) e reduções da fração de ejeção de ventrículo esquerdo de pelo menos 10% em três pacientes. Não houve toxicidade renal provavelmente pela adminsitração da ifosfamida em duas horas. A resposta foi avaliada pelos critérios de RECIST, com três respostas parciais, totalizando uma taxa de resposta de 14%. Seis respostas deveriam ser observadas para que o estudo completasse a inclusão de todos os pacientes programados. Como não se atingiu a taxa de resposta prevista, o protocolo foi fechado. Três mortes precoces foram observadas com suspeita de toxicidade. Após seguimento mediano de 11 meses, a SLP e a SG medianas foram 8,1 e 20,1 meses respectivamente. Pacientes com sarcoma sinovial e idade inferior a 45 anos apresentaram maior sobrevida na análise univariada. A expresão de ezrina foi positiva em 10 pacientes (47%) e houve tendência a uma correlação direta entre sua expressão e sobrevida mais longa (p=0,1191). Todos os pacientes com histologia sinovial foram positivos para ezrina (teste de Fischer, p= 0,0325). Este esquema de quimioterapia sequencial com dose densa de doxorubicina e ifosfamida foi tóxico, a taxa de resposta foi baixa em um grupo de pacientes com doença avançada e não pode ser empregado na prática clínica diária fora de protocolo de pesquisa / Advanced soft tissue sarcoma (STS) patients have a dismal prognosis. Efforts to increase benefit from chemotherapy are needed and dose-dense chemotherapy could be an option, since this approach has demonstrated survival benefit in breast cancer. On the other hand, the identification of a prognostic marker is essential to stratify which patients could benefit most from intensified strategies. Ezrin is a member of the ERM (ezrin, radixin, moesin) cytoeskeleton-associated protein family associated with invasion and metastasis, and has been pointed as important prognostic marker in sarcomas. The objective of this study was to explore the role of dose-dense doxorubicin- and ifosfamide-based chemotherapy in advanced high grade STS patients. Primary endpoint was response rate and secondary endpoints were overall survival (OS), progression free survival (PFS), toxicity profile, quality of life and pain control evaluation. Tumor ezrin immunoreactivity was an exploratory endpoint as a predictor of response to chemotherapy and as a prognostic factor in this population, trying to find which patients could benefit most from this intensified strategy. This prospective, single arm, phase II study included 21 advanced STS patients. Median age was 37 years (23-60y) and lower limbs were the most frequent primary site. Synovial, leiomyo and unclassified sarcoma were the most common histologies. Protocol consisted of 6 cycles of sequential dose-dense doxorubicin 30 mg/m2 D1-3 and ifosfamide 2.5 g/m2 D1-5 every 14 and 21 days, respectively, followed by seven days of hematopoietic support. The median doxorubicin and ifosfamide dose-intensities were, respectively, 42 mg/m2/week and 3.63 g/m2/week (93% and 87% of planned, respectively) and 15 patients (71%) received all cycles. Grade 3/4 toxicities occurred in 19 patients and 77/105 cycles, febrile neutropenia in 5 patients (six cycles) and three LVEF drops of at least 10%, one symptomatic. No renal toxicity was observed what could occurred due to the two-hour-schedule of ifosfamide. Responses were evaluated by RECIST criteria and three patients presented partial response (response rate of 14%). Six responses were necessary to the inclusion of the target population, however, this was not observed and the study was closed. Three deaths were probably related to toxicity. After a median follow-up was 11 months, PFS and OS were 8.1 months and 20.1 months, respectively. Patients with synovial sarcoma and those younger than 45y presented better survival at univariate analysis. Ezrin expression was positive in 10 patients (47%) and a trend was observed for a correlation between positive ezrin expression and longer survival (p= 0.1191). There was a statistically significant correlation between positive ezrin expression and synovial hystology (Fishers exact test, p= 0.0325). This sequential dosedense doxorubicin/ifosfamide-based chemotherapy protocol was toxic, response rate was low in advanced STS patients and can not be considered for routine practice outside clinical trials

Often predictor variables in regression models are measured with errors. This is known as an errors-in-variables (EIV) problem. The statistical analysis of the data ignoring the EIV is called naive analysis. As a result, the variance of the errors is underestimated. This affects any statistical inference that may subsequently be made about the model parameter estimates or the response prediction. In some cases (e.g. quadratic polynomial models) the parameter estimates and the model prediction is biased. The errors can occur in different ways. These errors are mainly classified into classical (i.e. occur in observational studies) or Berkson type (i.e. occur in designed experiments). This thesis addresses the problem of the Berkson EIV and their effect on the statistical analysis of data fitted using linear and nonlinear models. In particular, the case when the errors are dependent and have heterogeneous variance is studied. Both analytical and empirical tools have been used to develop new approaches for dealing with this type of errors. Two different scenarios are considered: mixture experiments where the model to be estimated is linear in the parameters and the EIV are correlated; and bioassay dose-response studies where the model to be estimated is nonlinear. EIV following Gaussian distribution, as well as the much less investigated non-Gaussian distribution are examined. When the errors occur in mixture experiments both analytical and empirical results showed that the naive analysis produces biased and inefficient estimators for the model parameters. The magnitude of the bias depends on the variances of the EIV for the mixture components, the model and its parameters. First and second Scheffé polynomials are used to fit the response. To adjust for the EIV, four different approaches of corrections are proposed. The statistical properties of the estimators are investigated, and compared with the naive analysis estimators. Analytical and empirical weighted regression calibration methods are found to give the most accurate and efficient results. The approaches require the error variance to be known prior to the analysis. The robustness of the adjusted approaches for misspecified variance was also examined. Different error scenarios of EIV in the settings of concentrations in bioassay dose-response studies are studied (i.e. dependent and independent errors). The scenarios are motivated by real-life examples. Comparisons between the effects of the errors are illustrated using the 4-prameter Hill model. The results show that when the errors are non-Gaussian, the nonlinear least squares approach produces biased and inefficient estimators. An extension of the well-known simulation-extrapolation (SIMEX) method is developed for the case when the EIV lead to biased model parameters estimators, and is called Berkson simulation-extrapolation (BSIMEX). BSIMEX requires the error variance to be known. The robustness of the adjusted approach for misspecified variance is examined. Moreover, it is shown that BSIMEX performs better than the regression calibration methods when the EIV are dependent, while the regression calibration methods are preferable when the EIV are independent.

No description available.

There is growing concern that current toxicological test methods are too slow and expensive to evaluate the safety of the thousands of chemicals in the Canadian economy. In this thesis, a novel zebrafish embryo test, with integrated behaviour, energy expenditure and gene transcription assays, was used to assess the hazard of a diverse suite of 29 chemicals. I hypothesized that points of departure (PODs) from the integrated test would be protective of the long-term toxic effects of these chemicals. I found that: 1) integrating alternative test methods enhanced the sensitivity of the zebrafish embryo acute toxicity (FET) test, 2) integrated results provided a holistic understanding of potential mechanisms of action and effects, and 3) transcriptional PODs were protective of PODs from traditional long-term and short-term juvenile and adult fish toxicity tests reported in the literature. This integrated zebrafish embryo test is a sensitive, informative and protective chemical hazard screening tool.

No description available.

No description available.

Stressful experiences in early life can have profound and lasting impacts on phenotypic development. In anthropogenic environments, organisms are increasingly exposed to evolutionarily novel stressors that may play a major role in shaping the phenotypic variation upon which natural selection acts. For instance, ionizing radiation persists in areas affected by nuclear reactor accidents, nuclear weapons testing, and the nuclear power production process. This thesis explored the dose-response effects of early life ionizing radiation exposure on life- history traits in the cricket (Acheta domesticus L.). Specifically, this work had two goals: (1) to examine the effects of early life radiation stress on the potential tradeoff between growth and self-maintenance, and (2) to explore the dose-dependent effects of juvenile radiation exposure on adult trait expression (particularly fecundity, offspring investment, and offspring fitness). It was found that exposure to moderate doses of radiation in early development resulted in a slower juvenile growth rate but increased survival in early adulthood, suggesting that self- maintenance was prioritized over growth. Despite the strong inhibitory effects of early life radiation on adult female body mass, age-specific fecundity was negatively impacted only at relatively high radiation doses. Crickets exposed to moderate radiation doses in early development laid larger eggs in adulthood relative to controls and these eggs had a greater hatching success, suggesting that radiation exposure had transgenerational effects on offspring performance. No noticeable effects of early life radiation exposure were detected on total and non-enzymatic antioxidant capacity or hydrogen peroxide levels in adult females. Together, this research indicates that a single, acute exposure to ionizing radiation in early life can affect phenotypic development in a complex, dose-dependent manner and that rather than being purely negative, phenotypic responses can be sustained or even enhanced. / Thesis / Master of Science (MSc) / Stressful experiences in early life can have lasting impacts on organismal development, but the extent to which early life stress is harmful is unclear. In human-dominated environments, pollutants such as ionizing radiation can be a significant form of developmental stress. This thesis explores the fitness-related effects of early life ionizing radiation exposure in the cricket, Acheta domesticus. Impacts on growth, longevity, fecundity, and offspring fitness are explored. This research indicates that early life stress can affect phenotypic development in a complex, dose-dependent manner and that rather than being purely negative, responses can be sustained or even enhanced.

<p dir="ltr">Waterhemp (<i>Amaranthus tuberculatus</i>)<i> </i>is one of the most problematic weeds in soybean production in the United States. The ability of waterhemp to quickly evolve resistance threatens the utility of many herbicides. The introduction of Xtend^®and Xtendflex^®soybeans allow for the in-season application of dicamba and glufosinate. With an increase in dicamba use in soybeans plus its continued use in corn, there have been many reports of dicamba failure on waterhemp.</p><p dir="ltr">Greenhouse dose response experiments were conducted to screen six populations of waterhemp for resistance to dicamba. Each population was compared to a known sensitive and known resistant population, with 50% growth reduction (GR₅₀) values of 39 g ae ha^-1and 226 g ae ha^-1, respectively. Low-level dicamba resistance was identified in all populations, as they had GR₅₀values that were different from the known sensitive and R:S ratios that varied from 1.7 to 4.4. Additionally, all six populations exhibited at least 50% survival at a 1/2X rate of dicamba where the sensitive only had 30% survival. Therefore, we can conclude that dicamba resistance in waterhemp is present in multiple counties in Indiana.</p><p dir="ltr">In addition to characterizing populations from Indiana, a growth monitoring study was conducted to determine how emergence timing impacted waterhemp growth. In 2021, plants that emerged in the earliest cohort were taller, had more branches, and accumulated more biomass in comparison to later emerging plants at six weeks after flagging. In 2022, drought conditions throughout the month of June impacted growth of earlier emerging plants, and waterhemp that emerged in the latest cohort were taller, had more branches, and accumulated more biomass than earlier emerging cohorts at six weeks after flagging. Seed yields per plant were low in both years, but all cohorts were able to produce seed. This research concludes that in years when soil sufficient moisture is available, earlier emerging waterhemp plants are competitive with crops and later emerging plants can still produce seed.</p><p dir="ltr">Additionally, field trials were conducted to determine herbicide programs in the Enlist^® and Xtendflex^® soybean systems that would best control a waterhemp population with multiple herbicide resistance. At 21 days after the second postemergence application, waterhemp control was highest in two pass systems. The addition of pyroxasulfone to the second postemergence application increased control of waterhemp in the Xtendflex^® system. Waterhemp densities were the lowest and soybean yield was the highest in two pass herbicide programs for both systems. The results indicate that waterhemp resistant to chemistries in HRAC Groups #2, #4, #5, #9, #14, and #27 was most effectively controlled by programs with two herbicides applications, either a preemergence followed by postemergence or two pass postemergence, and included 2,4-D and glufosinate in the postemergence application(s).</p><p dir="ltr">Finally, a waterhemp population from Francesville, IN was characterized for herbicide resistance via a series of field, greenhouse, and laboratory experiments. Preliminary laboratory analysis confirmed resistance to herbicide actives in the HRAC Groups #2 and #14 via target site mutations and to Group #9 via gene amplification. Field research trials indicated inadequate waterhemp control with preemergence applications of pendimethalin and atrazine and postemergence applications of herbicide actives from Groups #2, #9, #14, and #27 as well as glufosinate and dicamba. Greenhouse dose response experiments revealed GR₅₀values for the Francesville population that were significantly higher for dicamba, mesotrione, and topramezone than the known sensitive. R:S ratios of 4.4, 3.3, and 1.8, were documented for dicamba, mesotrione, and topramezone, respectively. Data from all experiments demonstrated that the Francesville population is resistant to herbicide actives in Groups #2, #4, #5, #9, #14, and #27.</p>

Introduction et objectifs : Alors que l'effet moteur de la lévodopa (L-dopa) dans la maladie de Parkinson (MP) est clair et établi, son effet sur la cognition demeure incertain. Les troubles cognitifs ont un impact important sur la qualité de vie et les études évaluant l'effet cognitif de ce médicament donnent des résultats encore divergents. L’objectif primaire de cette étude pilote est d’observer l’impact des doses cliniques de lévodopa sur la cognition. Un second objectif sera d'établir une courbe dose-réponse pour observer les différences potentielles. Méthodes : Cinq patients avec MP ont été évalués à l’aide de 2 tests cognitifs (CPT-II et Stroop) et 2 tests moteurs (Finger Tapping et UPDRS-III) en OFF (sevrage minimal de 12 heures) et en ON avec des doses croissantes de lévodopa (commençant à 50mg avec une augmentation de dose de 50mg par visite) jusqu’à l'observation d'une performance cognitive optimale ou d'effets secondaires. Une administration répétée des tests cognitifs a été faite à la première visite pour limiter l’effet d’apprentissage. Résultats : Le temps de réaction (RT) mesuré en millisecondes au CPT-II a augmenté (médiane 3.03%) après la prise de médicament alors que les erreurs ont légèrement diminué (médiane -9.92%). Au Stroop, l’effet d’interférence évalué selon les changements au temps d’inhibition mesuré en secondes était légèrement moindre sans changement dans les erreurs. Avec les doses prescrites, le RT a augmenté de 3,50% et le nombre d’erreurs est resté stable alors que les doses inférieures ont eu une moindre augmentation du RT tout en diminuant les erreurs. Dans le Stroop, les doses faibles ont amélioré le temps de près de 19% alors que les doses prescrites ont quant à elles diminué les erreurs. Malgré une certaine variabilité, la courbe dose-réponse indique que les erreurs diminuaient aux doses faibles et fortes dans le CPT-II alors que le RT augmentait généralement, ce qui pourrait indiquer un style de performance plus prudent. L’effet de la lévodopa sur l’interférence dans le Stroop variait légèrement sans tendances fixes mis à part le bénéfice observé par les doses faibles. Une importante variabilité a été observée dans les évaluations motrices entre les sujets ainsi qu'au sein du même sujet. Conclusion : Ces résultats indiquent qu’en général, le médicament ne semble pas avoir d’effet néfaste important sur l’attention et les fonctions exécutives évaluées auprès de ce groupe de patients parkinsoniens. L'effet cognitif des doses plus faibles semble leur être bénéfique et meilleur que les doses cliniquement prescrites. La relation dose-réponse démontre un effet cognitif variable de la lévodopa entre les doses, n'indiquant toutefois pas de tendances claires. / Background and objectives: While levodopa’s effect on motor symptoms in Parkinson’s disease (PD) has been largely characterized, its cognitive effect still remains without definite conclusion. Since cognitive impairment is an important feature of PD that impacts patients’ quality of life, it is important to establish levodopa’s effect on cognitive functions. Multiple studies regarding this subject remained without specific consensus. The main goal pursued in this study is to observe the effect of clinical doses of levodopa on attention and executive functions. A dose-response curve is also made with the escalating doses evaluated. Methods: Five PD patients were investigated OFF (minimal withdrawal of 12 hours) and ON levodopa (starting dose of 50mg escalating by 50mg per visit) with 2 cognitive (CPT-II and Stroop) and 2 motor (finger tapping and UPDRS-III) tests until reaching an optimal cognitive performance or showing signs of side effects. Practice sessions of the cognitive tests were done at the first visit. Results: While reaction time (RT) in milliseconds increased (median 3.03%), errors slightly decreased (median -9.92%) after medication intake in the CPT-II. Errors however did not change in the Stroop while time evaluated in seconds decreased. The CPT-II showed slowing at the prescribed doses of levodopa (3.5%) while lower doses improved errors with less increase of the RT. These small doses also improved the performance in the Stroop test with a 19% reduction in time while the prescribed doses improved errors instead. The dose-response curve indicates a reduction of errors in the CPT-II for low and high doses while time usually increased, showing a more cautious style. Besides the beneficial effect of low doses, the dose-response curve for the Stroop test did not show any specific tendencies in levodopa’s effect on interference. An important variability was observed in motor evaluations between and within subjects. Conclusion: These results indicate that levodopa does not seem to have an important deleterious effect on attention and executive functions evaluated in this group of parkinsonian patients and that low doses seem to even be beneficial and better than the ones usually taken by the patients. The dose-response curve showed that the cognitive effect of levodopa for these patients varies between the different doses without being clear on the tendencies.